Researchers are using mesenchymal stem cells [MSCs] in a clinical trial to treat the loss of function that nearly always results from traumatic brain injuries (TBIs). The trial focused on patients in the U.S. and Japan, who have traumatic brain injuries in the chronic stages. The researcher’s decision to use MSCs was predicated on their differentiation capabilities as well as their inherent anti-inflammatory properties. The MSCs in the trials are cultured to clinically significant numbers then implanted back into the affected areas of the brain, where they work to to restore damaged neurons in the brain, help regenerate blood vessels and reduce the inflammation that often occurs at the injury site.
The researchers observed a statistically significant improvement in the function of the arms and legs in nearly all patients. The implications of this successful clinical trial for the future of TBI sufferers is significant in that presently, there are no effective treatments for the effects of TBIs, the only option being physical therapy. Therefore, having an effective stem cell therapy could help thousands of patients regain function after suffering the debilitating effects of TBIs.
Advances in stem cell based regenerative treatments are creating more effective treatment options for patients suffering from a wide variety of disease, trauma and injury. To learn more about stem cells, and how families can bank their own valuable stem cells by recovering the very powerful dental pulp stem cells during routine dental procedures; such as wisdom teeth extractions or the during the loss of baby teeth, visit StemSave or call 877-783-6728 (877-StemSave) today.
The Future of Regenerative Medicine is Now™
To view the full article, click here.